-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Amphastar Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2024.
- Amphastar Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was $38M, a 4.97% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was $160M, a 16% increase year-over-year.
- Amphastar Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $160M, a 16% increase from 2023.
- Amphastar Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $138M, a 50.5% increase from 2022.
- Amphastar Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $91.4M, a 47.1% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)